Joey Harrington Publishes!


R3 Dr. Josephine Harrington published her new review “Should Metformin Remain First-Line Therapy for Patients with Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease? An Alternative Approach” today in Current Diabetes Reports.


Dr. Harrington reviews the evidence for cardiovascular effects of antihyperglycemic agents, proposing the major aim of therapy of type 2 diabetes should be to reduce CV events and deaths. In the face of newly developed diabetes therapies with proven CV safety, is metformin the best option to improve CV outcomes?


Dr. Harrington publishes this review with former UTSW IM resident and current UTSW cardiology fellow Natalia de Albuquerque Rocha, UTSW cardiology fellow Kershaw Patel , Dr. Subodh Verma, and UTSW Cardiologist Dr. Darren McGuire. The review can be found here.